I'm not sure Payne has to do alot of "selling". I think the mandated test results speak for themselves. You couldn't have had a better outcome outside of a cure.
Thought we might get some action in the stock yesterday but that nice sized bid is either gone or covered up at the moment. So not sure it is still there.
Regardless, it kinda looks like the stock is back to "watching paint dry" mode here with the volume tailing off. Sellers kinda put up a wall around the $20 mark which I think was dumb but too each his own. The chart and historical valuation had room to around the $23-$25 area and then I would have liked to see the stock take a rest between $20 and $25 but alas .... not as yet meant to be.
I would think a license agreement in this space would be a fairly standard contract. From there it's about money and who is responsible for what, when and contributing what to the license. I'm sure territory a factor here too. Worldwide license, US license, European License. ..... all part of the discussion. When lawyers get involved it is always a crapshoot as to how long something like this would take even if the animal pharma is hot on it. Lawyers throw cold water on everything. LOL. Anyway, I sure hope Payne is talking license at this point. The results were announced August 23rd. Its more than 2 months at this point and Payne should surely be talking license by now. I'd also like to know if there really is more than 1 global animal pharma in the mix at this stage or if 1 has dropped out. That could factor in as well.
Bottomline ... it has been nearly 20 years ...... the stock has surely had it's ups and downs and I can't complain having extracted my share of profits out of it over the years ........ but at this point ........... SHOW ME THE MONEY !!! Long suffering ZIVO longs deserve to see the fruits of their patience and suffering.
Amigo Mike
AI
Market Data 
Markets 
